P2X7R | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

17 results for “P2X7R”

Trials

A P2X7R Single Nucleotide Mutation Promotes Chronic Allograft Vasculopathy

200 participants · First posted Mar 10, 2014

P2X7 Receptor, Inflammation and Neurodegenerative Diseases

50 participants · First posted Apr 17, 2019

Antidepressant Trial With P2X7 Antagonist JNJ-54175446

142 participants · First posted Oct 4, 2019

Drugs

P2X7R Antagonists(Breye Therapeutics)

P2X7R antagonist (oral, dry age-related macular degeneration)

P2X7 antagonist

News

Glial Cell Immune Networks Drive Neuroinflammation in Glaucomatous Optic Nerve Degeneration

Lilly Discontinues P2X7 Inhibitor LY3857210 for Chronic Pain After Phase II Failure

Page 1 of 2